The results of the meta-analysis showed that high DSG2 expression was significantly associated with poor OS in NSCLC (HR = 1.54, 95% CI [1.11–2.15], I2 = 81%, random-effect model). The gene discussed is DSG2; the disease is non-small cell lung carcinoma.